Back to Results

Check Cap Ltd (MBAI)

Check Cap Ltd. is a clinical-stage medical diagnostics company focused on capsule-based screening technologies. The company was incorporated in 2004 and is based in Isfiya, Israel. Its common stock is listed on NASDAQ under the ticker MBAI. As an early-stage healthcare company, Check Cap’s business is centered on developing diagnostic products for screening applications.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Free Cash Flow / Net Income
NASDAQ-MBAI
$2.24
-7.8% Downside
Fair
$10
311.5% Upside
Bargain
Weak
0.0%
November 23, 2026
73.2x
15.9x
37.01 M
36.78 M
0.0%
49.8%
-237.9%
Valuation • Fair Value

Check Cap Ltd (NASDAQ-MBAI) Fair Value by Valuation Model

Review the available estimates for Check Cap Ltd (NASDAQ-MBAI), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$2.24

Estimated downside of 7.8% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$2.52

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0.37

Classic Ben Graham valuation formula reference.

Comps Fair Value

$1.89

Comparable-company valuation reference.

Analyst Price Target

$10

Analysts imply upside of 311.5%.

How to read these valuation models

Use the 6 available valuation references for Check Cap Ltd (NASDAQ-MBAI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Check Cap Ltd (NASDAQ-MBAI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.335 M

Current operating scale indicator.

Revenue Forecast

4.76 M

Forward revenue estimate.

EBITDA

567.397 K

Current operating profitability reference.

EBITDA Forecast

-16 K

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Check Cap Ltd (NASDAQ-MBAI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Check Cap Ltd (NASDAQ-MBAI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

FCF / Net Income

-237.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Check Cap Ltd (NASDAQ-MBAI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Check Cap Ltd (NASDAQ-MBAI)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 23, 2026

Days to Earnings

17

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Check Cap Ltd (NASDAQ-MBAI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Check Cap Ltd (NASDAQ-MBAI) Stock Forecast & Technical Outlook

Review Check Cap Ltd (NASDAQ-MBAI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Check Cap Ltd (NASDAQ-MBAI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Check Cap Ltd (NASDAQ-MBAI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Check Cap Ltd (NASDAQ-MBAI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Check Cap Ltd (NASDAQ-MBAI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Check Cap Ltd (NASDAQ-MBAI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Check Cap Ltd (NASDAQ-MBAI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Check Cap Ltd (NASDAQ-MBAI) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Check Cap Ltd (NASDAQ-MBAI) Stock FAQ

Data-supported answers about Check Cap Ltd (NASDAQ-MBAI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$2.24
Estimated downside 7.8%
Valuation Rating
Overvalued
Estimated downside of 7.8%
Analyst Target
$10
Implied upside 311.5%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Check Cap Ltd (NASDAQ-MBAI) is $2.24. This implies an estimated downside of 7.8% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 7.8% versus the current market price.

The available analyst price target for Check Cap Ltd (NASDAQ-MBAI) is $10. The analyst target implies estimated upside of 311.5%.

The current financial health read for Check Cap Ltd (NASDAQ-MBAI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Check Cap Ltd (NASDAQ-MBAI) is November 23, 2026.

The latest available data indicates no current dividend yield for Check Cap Ltd (NASDAQ-MBAI).

The current P/E ratio listed for Check Cap Ltd (NASDAQ-MBAI) is 73.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Check Cap Ltd is 37.01 M.

The current enterprise value listed for Check Cap Ltd is 36.78 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Check Cap Ltd is NASDAQ-MBAI, and the stock is listed on NASDAQ.

Check Cap Ltd (NASDAQ-MBAI) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Check Cap Ltd is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Check Cap Ltd is 49.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 196.7 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 162.4 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 128.3 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 127.6 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 64.704 B
BDX NYSE Becton Dickinson and Co Fair Value Fair Market Cap 58.168 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 57.971 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 52.86 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 52.302 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Fair Market Cap 37.867 B
ALC NYSE Alcon AG Fair Value Fair Market Cap 37.14 B
RMD NYSE ResMed Inc Fair Value Fair Market Cap 33.661 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 31.503 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Fair Market Cap 30.181 B
STE NYSE STERIS plc Fair Value Fair Market Cap 24.777 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Fair Market Cap 20.222 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 14.84 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 13.319 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 13.27 B
GKOS NYSE Glaukos Corp Fair Value Overvalued Market Cap 13.016 B